HLB Therapeutics Co.,Ltd.
KOSDAQ 115450.KQ
HLB Therapeutics Co.,Ltd. Share Price on January 14, 2025: USD 8.47
-
HLB Therapeutics Co.,Ltd. 52-week high Share Price is USD 12.12 on April 08, 2024, which is 43.09% above the current Share Price.
-
HLB Therapeutics Co.,Ltd. 52-week low Share Price is USD 2.82 on January 17, 2024, which is -66.76% below the current Share Price.
-
HLB Therapeutics Co.,Ltd. average Share Price for the last 52 weeks is USD 6.76.
| Date | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) |
|---|
| CEO | Mr. Doug Jang |
| IPO Date | March 26, 2010 |
| Location | |
| Headquarters | Parkview Office Tower |
| Employees | 98 |
| Sector | Health Care |
| Industries | |
HLB Therapeutics Co.,Ltd., a biotech company, develops pharmaceutical products in South Korea and internationally. It is developing GBT-201 using Thymosin beta for the treatment of ophthalmic diseases, such as dry eye syndrome and neurotrophic keratopathy; and OKN-007 for the treatment of glioblastoma brain tumor. It is also involved in the wholesale of vaccines, as well as manufactures electrical and electronic components, such as motors, pumps, and transformers. The company was formerly known as G-treeBNT Co., Ltd. and changed its name to HLB Therapeutics Co.,Ltd. in December 2021. HLB Therapeutics Co.,Ltd. was founded in 2000 and is headquartered in Seongnam, South Korea.
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email